ADMA Biologics/ US0008991046 /
2024-05-21 9:59:56 PM | Chg. +0.20 | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
9.61USD | +2.13% | 75,443 Turnover: 713,481.42 |
-Bid Size: - | -Ask Size: - | 9.62 | 9.34 |
GlobeNewswire
05-09
ADMA Biologics Announces First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
03-11
ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ ...
GlobeNewswire
03-05
ADMA Biologics to Participate in the Raymond James Institutional Investor Conference
GlobeNewswire
02-28
ADMA Biologics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business U...
GlobeNewswire
02-21
ADMA Biologics to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
GlobeNewswire
2023-12-18
ADMA Biologics Announces $135 Million Non-Dilutive Refinancing of Credit Facilities with Ares Manage...
GlobeNewswire
2023-12-12
ADMA Biologics Announces FDA Approval for BIVIGAM® in the Pediatric Patient Setting for Those 2 Year...
GlobeNewswire
2023-11-16
ADMA BioCenters Receives FDA Approval for its Tenth Plasma Collection Center, Located in Laurel, MD
GlobeNewswire
2023-11-08
ADMA Biologics Announces Third Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire
2023-11-01
ADMA Biologics to Report Third Quarter 2023 Financial Results on November 8, 2023
GlobeNewswire
2022-03-25
ADMA Biologics Announces FDA Approval of Extended Shelf Life for ASCENIV™ & BIVIGAM® from 24 to 36 M...
GlobeNewswire
2022-03-24
ADMA Biologics Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Business U...
GlobeNewswire
2022-03-21
ADMA Biologics to Report Fourth Quarter and Full Year 2021 Financial Results on March 24, 2022
GlobeNewswire
2022-03-07
ADMA BioCenters Receives FDA Approval for its Fifth Plasma Collection Center, Located in Conyers, GA
GlobeNewswire
2022-01-19
ADMA Biologics Announces Record Preliminary Fourth Quarter and Full Year 2021 Revenues and Provides ...
GlobeNewswire
2022-01-18
ADMA BioCenters Receives FDA Approval for its Fourth Plasma Collection Center Located in Goose Creek...
GlobeNewswire
2021-12-06
First Wave BioPharma’s CEO and President, James Sapirstein, to Participate in CEO Panel Discussion a...
GlobeNewswire
2021-11-17
ADMA Biologics Senior Vice President of Plasma Services Cyndi Tolman Elected to PPTA Source Board of...